These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16699031)

  • 21. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
    Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons.
    Posavad CM; Remington M; Mueller DE; Zhao L; Magaret AS; Wald A; Corey L
    J Immunol; 2010 Mar; 184(6):3250-9. PubMed ID: 20164419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.
    Mark KE; Wald A; Magaret AS; Selke S; Olin L; Huang ML; Corey L
    J Infect Dis; 2008 Oct; 198(8):1141-9. PubMed ID: 18783315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract.
    Posavad CM; Zhao L; Mueller DE; Stevens CE; Huang ML; Wald A; Corey L
    Mucosal Immunol; 2015 Jan; 8(1):115-26. PubMed ID: 24917455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-resident T cell-derived cytokines eliminate herpes simplex virus-2-infected cells.
    Roychoudhury P; Swan DA; Duke E; Corey L; Zhu J; Davé V; Spuhler LR; Lund JM; Prlic M; Schiffer JT
    J Clin Invest; 2020 Jun; 130(6):2903-2919. PubMed ID: 32125285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.
    Hensel MT; Peng T; Cheng A; De Rosa SC; Wald A; Laing KJ; Jing L; Dong L; Magaret AS; Koelle DM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.
    Thapa M; Carr DJ
    J Virol; 2009 Sep; 83(18):9486-501. PubMed ID: 19587047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
    Tang VA; Rosenthal KL
    J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.
    Koelle DM; Liu Z; McClurkan CL; Cevallos RC; Vieira J; Hosken NA; Meseda CA; Snow DC; Wald A; Corey L
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12899-904. PubMed ID: 14566059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes.
    Posavad CM; Huang ML; Barcy S; Koelle DM; Corey L
    J Immunol; 2000 Jul; 165(2):1146-52. PubMed ID: 10878394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection.
    Perry CL; Banasik BN; Gorder SR; Xia J; Auclair S; Bourne N; Milligan GN
    J Immunol Methods; 2016 Dec; 439():1-7. PubMed ID: 27659010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.
    Schiffer JT; Abu-Raddad L; Mark KE; Zhu J; Selke S; Koelle DM; Wald A; Corey L
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18973-8. PubMed ID: 20956313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamine supplementation suppresses herpes simplex virus reactivation.
    Wang K; Hoshino Y; Dowdell K; Bosch-Marce M; Myers TG; Sarmiento M; Pesnicak L; Krause PR; Cohen JI
    J Clin Invest; 2017 Jun; 127(7):2626-2630. PubMed ID: 28581445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
    Mo A; Musselli C; Chen H; Pappas J; Leclair K; Liu A; Chicz RM; Truneh A; Monks S; Levey DL; Srivastava PK
    Vaccine; 2011 Nov; 29(47):8530-41. PubMed ID: 21767588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.
    Kim M; Taylor J; Sidney J; Mikloska Z; Bodsworth N; Lagios K; Dunckley H; Byth-Wilson K; Denis M; Finlayson R; Khanna R; Sette A; Cunningham AL
    J Immunol; 2008 Nov; 181(9):6604-15. PubMed ID: 18941251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
    Lee AJ; Ashkar AA
    Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4
    Bourne N; Perry CL; Banasik BN; Miller AL; White M; Pyles RB; Schäfer H; Milligan GN
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.